Inventor · Yeadon, PA, US

Carl H. June

132Patents
34h-index
107Co-inventors
93Inventor score

Filing activity: Feb 17, 1994 → Mar 28, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6352694B1 Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells Chemistry; Metallurgy 442 Expired
US6534055B1 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 388 Expired
US6905680B2 Methods of treating HIV infected subjects Chemistry; Metallurgy 323 Expired
US6887466B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 322 Expired
US6905681B1 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 320 Expired
US5858358A Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 299 Expired
US8906682B2 Methods for treatment of cancer Chemistry; Metallurgy 299 Active
US7175843B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 286 Expired
US7232566B2 Methods for treating HIV infected subjects Chemistry; Metallurgy 277 Expired
US7144575B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 274 Expired
US6692964B1 Methods for transfecting T cells Chemistry; Metallurgy 247 Expired
US8911993B2 Compositions for treatment of cancer Chemistry; Metallurgy 230 Active
US7172869B2 Methods for transfecting T cells Physics 225 Expired
US7067318B2 Methods for transfecting T cells Physics 219 Expired
US8916381B1 Methods for treatment of cancer Chemistry; Metallurgy 178 Active
US9102761B2 Compositions for treatment of cancer Chemistry; Metallurgy 165 Active
US9101584B2 Methods for treatment of cancer Chemistry; Metallurgy 165 Active
US9102760B2 Compositions for treatment of cancer Chemistry; Metallurgy 165 Active
US8975071B1 Compositions for treatment of cancer Chemistry; Metallurgy 163 Active
US9499629B2 Use of chimeric antigen receptor-modified T-cells to treat cancer Chemistry; Metallurgy 116 Active
US9464140B2 Compositions and methods for treatment of cancer Chemistry; Metallurgy 97 Active
US8637307B2 Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool Chemistry; Metallurgy 97 Active
US9394368B2 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor Chemistry; Metallurgy 94 Active
US7754482B2 Artificial antigen presenting cells and uses therefor Chemistry; Metallurgy 94 Active
US6632789B1 Methods for modulating T cell responses by manipulating intracellular signal transduction Human Necessities 89 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.